A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...
This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...
HealthDay News — Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within one year, with higher discontinuation rates seen for those without ...
Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...
Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...
GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.
GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.
RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent ...
Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...
Medscape Medical News, November 14, 2024 GLP-1 Prescribing Decisions ... 2024 ATA 2024 Managing Long-Term Health Risks in Thyroid Cancer Survivors ATA 2024 spotlighted new research to help ...